TNFSF13 Antikörper
TNFSF13
Reaktivität: Human
WB, ELISA
Wirt: Kaninchen
Polyclonal
unconjugated
Produktnummer ABIN2133944
-
-
Target
Alle TNFSF13 Antikörper anzeigen
-
TNFSF13
(Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))
-
Reaktivität
-
Human
-
Wirt
-
Kaninchen
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser TNFSF13 Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), ELISA
-
Aufreinigung
-
APRIL antibody was purified by Antigen Affinity chromatography
-
Immunogen
-
APRIL antibody was raised in Rabbit using Human APRIL as the immunogen
-
Isotyp
-
IgG
-
Top Product
-
Discover our top product TNFSF13 Primärantikörper
-
-
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Konzentration
-
Lot specific
-
Buffer
-
PBS buffer with 0.02 % Sodium Azide and 50 % Glycerol, pH 7.3
-
Konservierungsmittel
-
Sodium azide
-
Vorsichtsmaßnahmen
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
-
Avoid repeated freeze/thaw cycles
-
Lagerung
-
4 °C/-20 °C
-
Informationen zur Lagerung
-
Store at 4 °C for short term storage and -20 °C for long term storage
-
-
Target
-
TNFSF13
(Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))
-
Andere Bezeichnung
-
APRIL (TNFSF13 Produkte)
-
Synonyme
-
APRIL antikoerper, CD256 antikoerper, TALL-2 antikoerper, TALL2 antikoerper, TRDL-1 antikoerper, ZTNF2 antikoerper, 2310026N09Rik antikoerper, April antikoerper, Tall2 antikoerper, Trdl1 antikoerper, SLAN antikoerper, ANP32B antikoerper, april antikoerper, tnf13 antikoerper, TNLG7B antikoerper, TNF superfamily member 13 antikoerper, tumor necrosis factor (ligand) superfamily, member 13 antikoerper, acidic leucine-rich nuclear phosphoprotein 32 family member B antikoerper, TNFSF13 antikoerper, Tnfsf13 antikoerper, LOC494442 antikoerper, tnfsf13 antikoerper
-
Pathways
-
Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
-